DK1990420T3 - Fremgangsmåde til detektering af in vivo-aktiviteten af neurotrypsin, anvendelse af fremgangsmåden og anvendelse af det C-terminale 22-kDa-fragment af agrin som biomarkør ved diagnose og overvågning af neurotrypsin-relaterede forstyrrelser - Google Patents

Fremgangsmåde til detektering af in vivo-aktiviteten af neurotrypsin, anvendelse af fremgangsmåden og anvendelse af det C-terminale 22-kDa-fragment af agrin som biomarkør ved diagnose og overvågning af neurotrypsin-relaterede forstyrrelser

Info

Publication number
DK1990420T3
DK1990420T3 DK07009398.4T DK07009398T DK1990420T3 DK 1990420 T3 DK1990420 T3 DK 1990420T3 DK 07009398 T DK07009398 T DK 07009398T DK 1990420 T3 DK1990420 T3 DK 1990420T3
Authority
DK
Denmark
Prior art keywords
neurotrypsin
agrin
biomarker
diagnosis
monitoring
Prior art date
Application number
DK07009398.4T
Other languages
English (en)
Inventor
Peter Sonderegger
Stefan Hettwer
Alexander Stephan
Kazumasa Miyai
Beat Kunz
Original Assignee
Neurotune Ag
Univ Zuerich
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neurotune Ag, Univ Zuerich filed Critical Neurotune Ag
Application granted granted Critical
Publication of DK1990420T3 publication Critical patent/DK1990420T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/37—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/81—Protease inhibitors
    • G01N2333/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • G01N2333/811—Serine protease (E.C. 3.4.21) inhibitors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/12—Pulmonary diseases
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/34—Genitourinary disorders
    • G01N2800/347—Renal failures; Glomerular diseases; Tubulointerstitial diseases, e.g. nephritic syndrome, glomerulonephritis; Renovascular diseases, e.g. renal artery occlusion, nephropathy

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
DK07009398.4T 2007-05-10 2007-05-10 Fremgangsmåde til detektering af in vivo-aktiviteten af neurotrypsin, anvendelse af fremgangsmåden og anvendelse af det C-terminale 22-kDa-fragment af agrin som biomarkør ved diagnose og overvågning af neurotrypsin-relaterede forstyrrelser DK1990420T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP07009398A EP1990420B1 (en) 2007-05-10 2007-05-10 Method for the detection of the in-vivo activity of neurotrypsin, use of the method and use of the C-terminal 22-kDa fragment of agrin as biomarker in diagnosis and monitoring of neurotrypsin-related disturbances

Publications (1)

Publication Number Publication Date
DK1990420T3 true DK1990420T3 (da) 2010-11-15

Family

ID=38180345

Family Applications (1)

Application Number Title Priority Date Filing Date
DK07009398.4T DK1990420T3 (da) 2007-05-10 2007-05-10 Fremgangsmåde til detektering af in vivo-aktiviteten af neurotrypsin, anvendelse af fremgangsmåden og anvendelse af det C-terminale 22-kDa-fragment af agrin som biomarkør ved diagnose og overvågning af neurotrypsin-relaterede forstyrrelser

Country Status (16)

Country Link
US (1) US20100240083A1 (da)
EP (1) EP1990420B1 (da)
JP (1) JP2010526994A (da)
CN (1) CN101680022A (da)
AT (1) ATE477329T1 (da)
AU (1) AU2008250733A1 (da)
BR (1) BRPI0811429A2 (da)
CA (1) CA2692132A1 (da)
CY (1) CY1111602T1 (da)
DE (1) DE602007008370D1 (da)
DK (1) DK1990420T3 (da)
ES (1) ES2350254T3 (da)
PL (1) PL1990420T3 (da)
PT (1) PT1990420E (da)
SI (1) SI1990420T1 (da)
WO (1) WO2008138474A1 (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2484695A1 (en) * 2011-02-04 2012-08-08 Neurotune AG A method for the production of hybridoma cell lines producing monoclonal antibodies capable to specifically binding to a human C44-fragment of agrin
EP2631657A1 (en) * 2012-02-25 2013-08-28 Neurotune AG Immunoassay for the detection of the 22kDa C-terminal fragment (CAF) of agrin
US20160274126A1 (en) * 2012-11-13 2016-09-22 William Beaumont Hospital Biomarkers for the diagnosis of interstitial cystitis
CN111727038B (zh) * 2018-01-17 2025-05-13 南安普顿大学 肌肉减少症和nad缺乏的风险预测及分级方法
US11564983B1 (en) * 2021-08-20 2023-01-31 Betagen Scientific Limited Efficient expression system of SARS-CoV-2 receptor binding domain (RBD), methods for purification and use thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4920675B2 (ja) * 2005-03-30 2012-04-18 ユニバーシティ・オブ・チューリッヒ ニューロトリプシン阻害剤とその判定
US20100095387A1 (en) * 2005-07-15 2010-04-15 Martin Smith Methods and reagents for screening new drugs and for treating ion pump associated disorders and diseases

Also Published As

Publication number Publication date
EP1990420A1 (en) 2008-11-12
CA2692132A1 (en) 2008-11-20
EP1990420B1 (en) 2010-08-11
JP2010526994A (ja) 2010-08-05
PT1990420E (pt) 2010-11-04
AU2008250733A1 (en) 2008-11-20
DE602007008370D1 (de) 2010-09-23
ATE477329T1 (de) 2010-08-15
SI1990420T1 (sl) 2010-12-31
PL1990420T3 (pl) 2011-01-31
BRPI0811429A2 (pt) 2016-05-17
ES2350254T3 (es) 2011-01-20
CN101680022A (zh) 2010-03-24
CY1111602T1 (el) 2015-10-07
WO2008138474A1 (en) 2008-11-20
US20100240083A1 (en) 2010-09-23

Similar Documents

Publication Publication Date Title
WO2012142608A3 (en) Oral end tidal carbon dioxide probe for diagnosing pulmonary arterial hypertension
WO2009131655A3 (en) Automated assessment of optic nerve head with spectral domain optical coherence tomograph
WO2008098087A3 (en) Optical systems and methods for rationmetric measurement of blood glucose concentration
BRPI0913578A2 (pt) diagnose de melanoma e lentigo solar por análise de ácido nucléico
WO2013040099A3 (en) Sepsis prognosis biomarkers
WO2008014132A3 (en) Combination analyte measurement device and method of use
IN2014MN02060A (da)
EP2401678A4 (en) METHOD FOR DETECTION OF IMMINENT ANALYTICAL FAILURE OF NETWORK DIAGNOSTIC CLINICAL ANALYZERS
ES2687469T3 (es) Marcadores autoanticuerpos para el diagnóstico de traumatismo craneoencefálico
WO2014066913A3 (en) Health diagnostic systems and methods
WO2008114224A3 (en) Method and device for substance measurement
GB201009641D0 (en) Methods of monitoring conditions by sequence analysis
MX342178B (es) Kit guiado de prueba estructurada.
EP2770328A3 (en) Method to diagnose pancreatic cancer
WO2010136163A8 (en) Secernin-1 as a marker for cancer
EP2573192A4 (en) METHOD AND KIT FOR DIAGNOSIS OF AIM-MEDIATED ILLNESSES
DK1990420T3 (da) Fremgangsmåde til detektering af in vivo-aktiviteten af neurotrypsin, anvendelse af fremgangsmåden og anvendelse af det C-terminale 22-kDa-fragment af agrin som biomarkør ved diagnose og overvågning af neurotrypsin-relaterede forstyrrelser
WO2014004889A3 (en) Plasma analytes predict diagnosis and prognosis of thoracic aortic aneurysm
ATE537454T1 (de) Verfahren zum beurteilen von herzinsuffizienz bei patienten mit vorhofflimmern mittels gdf-15
WO2010099137A3 (en) In situ methods for monitoring the emt status of tumor cells in vivo
DE602006016853D1 (de) Blutdruckmessgerät für die genaue blutdruckmessung
BR112015014232A2 (pt) lesão renal aguda
ATE468535T1 (de) Verwendung von nnmt als marker für lungenkrebs
WO2010144553A3 (en) Methods for diagnosing blood vessel reocclusion
EP2326952A4 (en) BIOMARKERS, KITS AND METHODS FOR DIAGNOSING, MONITORING AND / OR STADIFYING ALZHEIMER'S DISEASE